Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)
Latest Information Update: 10 Jun 2024
At a glance
- Drugs Palbociclib (Primary) ; Aromatase inhibitors; Fulvestrant
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- Acronyms SIRI
- Sponsors Pfizer
- 05 Jun 2024 Planned End Date changed from 31 Dec 2022 to 31 Aug 2024.
- 05 Jun 2024 Planned primary completion date changed from 31 Dec 2022 to 31 Aug 2024.
- 12 Dec 2022 Planned End Date changed from 31 Mar 2021 to 31 Dec 2022.